EGFR and cancer: EGFRV948R transfection retained STAT3 phosphorylation in EGFR−/−, TMEM25−/− TNBC cells, strongly suggesting that EGFR can phosphorylate STAT3 in the monomeric form in the absence of TMEM25 and thereby relays sustainable proliferative signals to cancer cells to provide the growth advantage.